Innospec Inc. (IOSP)
NASDAQ: IOSP · Real-Time Price · USD
99.23
-0.32 (-0.32%)
At close: Nov 3, 2026, 4:00 PM EST
97.60
-1.63 (-1.64%)
Pre-market: Nov 4, 2026, 4:25 AM EST
Innospec Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,874 | 1,778 | 1,845 | 1,949 | 1,964 | 1,483 | |
Revenue Growth | 4.73% | -3.65% | -5.31% | -0.76% | 32.38% | 24.33% |
Cost of Revenue | 1,356 | 1,286 | 1,303 | 1,358 | 1,377 | 1,049 |
Gross Profit | 518.3 | 492.4 | 542.9 | 591.1 | 586.7 | 434.9 |
Selling, General & Admin | 304.1 | 285.4 | 298.1 | 373.6 | 355.9 | 261.8 |
Research & Development | 55.2 | 51 | 56.5 | 49 | 38.7 | 37.4 |
Operating Expenses | 359.3 | 336.4 | 354.6 | 422.6 | 394.6 | 299.2 |
Operating Income | 159 | 156 | 188.3 | 168.5 | 192.1 | 135.7 |
Interest Expense | - | - | - | - | -1.1 | -1.5 |
Interest & Investment Income | 3.9 | 9.2 | 9.3 | 2.3 | - | - |
Currency Exchange Gain (Loss) | 1.7 | 1.7 | 4.9 | 3.6 | -6.4 | -1.6 |
Other Non Operating Income (Expenses) | 3.4 | -2 | -2.5 | - | - | - |
EBT Excluding Unusual Items | 168 | 164.9 | 200 | 174.4 | 184.6 | 132.6 |
Merger & Restructuring Charges | - | -0.9 | - | - | - | - |
Gain (Loss) on Sale of Assets | - | 0.2 | 0.2 | - | - | 1.8 |
Asset Writedown | - | -42 | - | - | - | - |
Other Unusual Items | 5.4 | 15.9 | -159 | - | - | - |
Pretax Income | 173.4 | 138.1 | 41.2 | 174.4 | 184.6 | 134.4 |
Income Tax Expense | 33.4 | 21.5 | 5.6 | 35.3 | 51.6 | 41.3 |
Net Income | 140.4 | 116.6 | 35.6 | 139.1 | 133 | 93.1 |
Net Income to Common | 140.4 | 116.6 | 35.6 | 139.1 | 133 | 93.1 |
Net Income Growth | - | 227.53% | -74.41% | 4.59% | 42.86% | 224.39% |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 25 | 25 | 25 |
Shares Change | -0.45% | -0.50% | 0.39% | 0.16% | 0.52% | 0.30% |
EPS (Basic) | 5.68 | 4.69 | 1.43 | 5.60 | 5.37 | 3.78 |
EPS (Diluted) | 5.67 | 4.67 | 1.42 | 5.56 | 5.32 | 3.75 |
EPS Growth | - | 228.87% | -74.46% | 4.51% | 41.87% | 223.28% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 45.6 | 88 | 143.1 | 145.2 | 42.1 | 54.1 |
Free Cash Flow Per Share | 1.84 | 3.52 | 5.70 | 5.80 | 1.69 | 2.18 |
Dividend Per Share | 0.870 | 1.710 | 1.550 | 1.410 | 1.280 | 1.160 |
Dividend Growth | -46.63% | 10.32% | 9.93% | 10.16% | 10.35% | 11.54% |
Gross Margin | 27.66% | 27.69% | 29.42% | 30.33% | 29.88% | 29.32% |
Operating Margin | 8.48% | 8.77% | 10.20% | 8.65% | 9.78% | 9.15% |
Profit Margin | 7.49% | 6.56% | 1.93% | 7.14% | 6.77% | 6.28% |
Free Cash Flow Margin | 2.43% | 4.95% | 7.75% | 7.45% | 2.14% | 3.65% |
EBITDA | 197.9 | 199.6 | 231.8 | 207.8 | 231.8 | 178.1 |
EBITDA Margin | 10.56% | 11.23% | 12.56% | 10.66% | 11.80% | 12.01% |
D&A For EBITDA | 38.9 | 43.6 | 43.5 | 39.3 | 39.7 | 42.4 |
EBIT | 159 | 156 | 188.3 | 168.5 | 192.1 | 135.7 |
EBIT Margin | 8.48% | 8.77% | 10.20% | 8.65% | 9.78% | 9.15% |
Effective Tax Rate | 19.26% | 15.57% | 13.59% | 20.24% | 27.95% | 30.73% |